CIK 0001880438
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AN2 Therapeutics, Inc.
Sign in to watch- Ticker
- ANTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 820606654
- Phone
- +1 650-331-9090
- Business address
- 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $11,602
- in 1 filing
- Open-market sales, last 90 days
- $117,428
- in 4 filings, $104K under 10b5-1 plans
Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 94 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Eizen Joshua M See Remarks | Sale | −2,826 | $4.22 | $12K | 207,546 |
| 2026-10-12 | Marks Gilbert Lynn Director | Grant or award | +2,283 | 84,156 | ||
| 2026-10-12 | Martin Patricia A. Director | Grant or award | +389 | 19,252 | ||
| 2026-10-12 | Aziz Kabeer Director | Grant or award | +2,465 | 61,571 | ||
| 2026-09-15 | Trenor Cameron C. III Chief Medical Officer | Grant or award | +116,667 | 116,667 | ||
| 2026-09-15 | Trenor Cameron C. III Chief Medical Officer | Grant or award · Stock Option (right to by) | +233,333 | 233,333 | ||
| 2026-09-09 | Readnour Robin Shane Director | Sale 10b5-1 | −523 | $6.02 | $3K | 557,467 |
| 2026-09-09 | Readnour Robin Shane Director | Sale 10b5-1 | −585 | $6.02 | $4K | 624,765 |
| 2026-09-08 | Readnour Robin Shane Director | Sale 10b5-1 | −4,725 | $6.02 | $28K | 557,990 |
| 2026-09-08 | Readnour Robin Shane Director | Sale 10b5-1 | −5,294 | $6.02 | $32K | 625,350 |
| 2026-09-03 | Readnour Robin Shane Director | Sale 10b5-1 | −2,877 | $6.07 | $17K | 562,715 |
| 2026-09-03 | Readnour Robin Shane Director | Sale 10b5-1 | −3,223 | $6.07 | $20K | 630,644 |
| 2026-09-01 | Williams Sarah Joanne Principal Accounting Officer | Sale | −272 | $5.53 | $2K | 66,311 |
| 2026-09-01 | FitzPatrick Margaret M Director | Purchase | +2,098 | $5.53 | $12K | 10,708 |
| 2026-08-17 | Readnour Robin Shane Director | Sale 10b5-1 | −16,696 | $6.01 | $100K | 565,592 |
| 2026-08-17 | Readnour Robin Shane Director | Sale 10b5-1 | −18,706 | $6.01 | $112K | 633,867 |
| 2026-08-14 | Zakrzewski Joseph S Director | Gift | −405,880 | 0 | ||
| 2026-07-10 | Aziz Kabeer Director | Grant or award | +2,852 | 59,106 | ||
| 2026-07-10 | Marks Gilbert Lynn Director | Grant or award | +2,789 | 81,873 | ||
| 2026-07-10 | Martin Patricia A. Director | Grant or award | +766 | 18,863 |
Page 1 of 10 · 191 trades